-
Five Contemporary Drug Launch Phenotypes Every Pharma Marketer Should Know
Sales and marketing efforts behind a new drug launch can vary significantly by brand and this post highlights five distinct...
-
Lilly’s endocrinology-centric launch of Trulicity into T2D
The Type 2 diabetes (T2D) market is composed of dozens of agents that span a multitude of classes (e.g., GLP-1, SGLT2, and...
-
Gilead’s orchestrated HCV market development activity
Gilead’s HCV franchise had a massive 2014, generating $12.4B in revenue for the full calendar year. Gilead was able...
-
Tracking Roche’s next-gen anti-CD20 launch
Rituxan (rituximab) is an incredibly successful drug for Roche, generating billions of dollars across multiple indications each year. Roche’s...